Loading…
Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis
Background The effect of Helicobacter pylori ( H. pylori ) eradication on gastric cancer (GC) prevention is controversial. Intestinal metaplasia (IM) seems to be a “point of no return” in the precancerous cascade. We performed a meta-analysis of randomized controlled trials (RCTs) to illustrate this...
Saved in:
Published in: | Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2016-01, Vol.19 (1), p.166-175 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
The effect of Helicobacter pylori (
H. pylori
) eradication on gastric cancer (GC) prevention is controversial. Intestinal metaplasia (IM) seems to be a “point of no return” in the precancerous cascade. We performed a meta-analysis of randomized controlled trials (RCTs) to illustrate this issue.
Materials and Methods
The MEDLINE, EMBASE, Cochrane Library were searched for relevant RCTs that were published in any language up to March 2014. By dividing participants into subgroups based on their baseline diagnoses as group |
---|---|
ISSN: | 1436-3291 1436-3305 |
DOI: | 10.1007/s10120-015-0462-7 |